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What is TO-REACH? 
Learning from other countries is a key tool for helping 
health systems to improve. Europe offers a unique potential 
for learning between health systems, bringing together 
many health systems with similar aims but all organized in 
different ways. However, these different approaches also 
mean that the process of learning from each other is not 
straightforward. Because each system is organized, 
governed and financed differently, what works in one place 
will not work identically in another. We need special 
methods to analyse how care has been organized well in 
one place; to disentangle the innovation and its local 
context; and then to transfer that innovation to a new, 
different context elsewhere. We need capacity for the 
research and application of these processes, which is 
currently seriously under-developed across Europe. And, as 
this process depends on working together across countries, 
we need a shared set of key priority areas on which we can 
collaborate. 
The TO-REACH project – Transfer of Organizational 
innovations for Resilient, Effective, equitable, Accessible, 
sustainable and Comprehensive Health services and systems 
– was funded by the European Union’s Horizon 2020 
programme to help meet these needs. Its overall aim was to 
prepare for establishing a joint European research 
programme on health services and systems that will 
contribute to the resilience, effectiveness, equity, 
accessibility, sustainability and comprehensiveness of health 
services and systems. It brought together a wide range of 
partners (listed below). The key results from the TO-REACH 
project are set out in two policy briefs: one sets out how we 
can improve our ability for European health systems to learn 
from each other (this policy brief), while the other focuses 
on what topics this work should address (see the 
complementary policy brief by Hansen et al., 2021). These 
messages are summarized in Figure 1 below. 
The COVID-19 pandemic has illustrated both the challenges 
and the opportunities of learning between health systems. 
Faced with the pandemic, health systems in Europe and 
beyond have been seeking to learn lessons from each other 
about how best to respond and to implement those lessons 
as quickly as possible, and often at remarkable speed. The 
speed with which some lessons have been shared and 
implemented in days or weeks highlights just how slow our 
existing processes normally are in comparison. But the 
challenges of learning from each other have also been 
highlighted, with a lack of clear means to identify the best 
innovations, how they exist within their organizational and 
system contexts, what is needed to transfer them elsewhere, 
and an overall lack of capacity for carrying out these tasks. 
While the TO-REACH project work was carried out before 
the pandemic struck, the challenges and potential solutions 
this project has identified will be even more relevant in the 
future reshaped by COVID-19. These findings will be 
especially important for the future European Partnership on 
Health and Care Systems Transformation envisaged under 
the Horizon Europe Research and Innovation Framework 
Programme. 
Source: TO-REACH Strategic Research Agenda, https://to-reach.eu/wp-content/uploads/2019/05/TO-REACH-draft-SRA_May-16-2019_FinalV.pdf 
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Key messages 
The TO-REACH project addressed what the key priority 
areas are where European health systems can learn from 
each other and how we can improve their ability to do so. 
This brief is one of a pair of policy briefs and looks at the 
how – that is, how health systems can learn from each 
other. It also looks at what determines success and failure in 
the transfer of service and policy innovations and in scale-
up.  
• Innovation transfer is more successful given certain 
attributes or contextual conditions:  
– It is easier to adopt and implement innovations that 
have a clear-cut advantage in (cost) effectiveness.  
– Knowing that the innovation will address the service or 
policy challenge, along with understanding the 
sociocultural context, is crucial in realising the potential 
for successful transfer.  
– Innovations have to be translated and customized to 
improve ‘fit’ with local conditions. 
– Customization requires a good understanding of the 
innovation itself; of how the innovation interacts with 
its context; and of the process of transfer itself.  
– Experts and decision-makers, individuals, organizations 
and networks, all play a role in innovation transfer and 
diffusion. Securing their commitment encourages 
success.  
• Collaborative European research could most usefully 
address the aspects of innovation transfer that need to be 
understood better, including:  
– The particular health system characteristics and the 
wider context elements that are conducive to 
adopting, implementing and sustaining service and 
policy innovations.  
– How different levels of health systems manage 
innovation and the impact of these differences on the 
transfer of service and policy innovations across 
regions and countries.  
– The nature of the evidence needed to inform the 
transfer of innovations, including the types of 
knowledge needed in different settings and conditions 
and how they are used, as well as what gets lost in 
‘policy translation’.  
– The impact of service and policy innovations on health 
system performance, including any unintended 
consequences.  
– The research methodologies that can best advance 
cross-country learning, including how to identify 
country ‘units’ for comparison; how to handle context; 
and addressing measurement problems.  
• European collaboration on research would provide a solid 
basis for addressing the challenges of health and care 
systems transformation and would help to maximise 
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Executive summary 
Responding to health systems challenges necessitates 
innovations in service organization and delivery  
Health systems in Europe face numerous challenges and 
there is an urgent need for innovative solutions to ensure 
that they continue to provide accessible health and long-
term care that is of high quality, responsive, affordable and 
financially sustainable, while also addressing the underlying 
determinants of health to improve population health overall.  
Innovations in the health and care sectors are often linked to 
technology. But introducing new technologies into a given 
system is not just about adding new, improved goods or 
services. They will affect the ways health services are 
organized and delivered. At the same time, the complex 
challenges faced by the European health systems mean that 
we must focus on innovation in service organization and 
delivery in their own right, considering the entire care 
continuum.  
There is great potential for European health 
systems to learn from each other through rigorous 
comparative cross-national health services and 
 systems research 
Countries in Europe and beyond have been embarking on a 
wide range of reforms to address the various challenges they 
face. While reform efforts reflect the different ways in which 
health systems are financed, organized and governed, as 
well as their wider national contexts, there is also great 
potential to learn from the experiences of different 
countries. Rigorous comparative cross-national health 
services and systems research can help in understanding the 
range of approaches countries have adopted to address 
similar problems and offer opportunities for reconsideration 
of policies, cross-fertilization or even policy transfer. 
This policy brief sheds light on how health systems 
can learn from each other about transferring service 
and policy innovations 
For such cross-country learning to be possible and effective, 
we need to better understand what we know (and what we 
don’t know) about how health systems can learn from each 
other, as well as the conditions for and determinants of 
successes and failures in the transfer (and possible scale-up) 
of service and policy innovations between regions and 
countries.  
This policy brief looks at the evidence base around service 
and policy transfer between regions and countries, 
identifying what we already know as well as the main gaps 
in our current knowledge and understanding of the 
transferability of service and policy innovations in health 
services and systems.  
We already have a good understanding of the main 
conditions for and determinants of successes and 
failures in transferring service and policy 
innovations. These are: 
• A good understanding of the main features of the 
innovation 
Systematic research has identified several attributes that 
mean innovations are more easily adopted and 
implemented. These include the innovation: (i) having a 
clear-cut advantage in (cost-) effectiveness relative to 
alternatives; (ii) being compatible with potential adopters’ 
values, norms and perceived needs; (iii) being perceived as 
‘simple’ to understand and use by key stakeholders; (iv) 
providing the opportunity for intended users to ‘try it’ on a 
limited basis; (v) having observable benefits that can be seen 
by intended adopters; and (vi) being adaptable or otherwise 
modifiable to the needs of potential adopters. 
However, even when the innovation has all these attributes, 
it may still not be adopted. This is because decisions about 
adopting a given innovation do not occur in isolation but are 
determined by the interactions of the innovation, the 
intended adopter(s) and the particular context within which 
the innovation is to be introduced. 
• Recognition of the sociocultural context of 
transferring and receiving services and systems  
Successful cross-national learning not only requires analysis 
of the relevant institutions, but also of the wider political 
and economic system within which the health systems 
operate, along with the roles, interactions and relationships 
of the main actors, which may change over time and impact 
on the transferability of innovative practices. Policy-makers 
and researchers typically look for examples of innovations in 
countries that are close in terms of geography (neighbouring 
countries), shared history, language or the availability of 
published evidence. Key to any transfer is understanding 
whether and how the innovation in a given setting will 
address the policy challenge in the receiving setting. 
Depending on the degree to which the policy problems are 
(dis)similar, this may mean that the innovation has to be 
adapted or, if it is not suitable, other options may need to be 
explored. 
• Translation and customization of service and policy 
innovations to improve ‘fit’ with local conditions 
Innovations need to be translated or adapted to the 
receiving context. This requires an understanding of a range 
of processes along the transfer pathway. For example, the 
innovation will interact with the immediate context within 
which it ‘works’ (e.g. organization, region) in the originating 
setting and at the same time its workings will be affected by 
the wider system context. These factors might affect 
behaviour and the outcomes produced. Also, translation or 
adaptation already occur as services or policies move, before 
the actual transfer to a different setting takes place, because 
various actors will bring their own interpretations to the 
process. Finally, the nature of knowledge about the 
innovation includes not only codified, documented 
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information that is more readily available, but also tacit, local 
‘know-how’ or insider knowledge. Such knowledge is more 
difficult to communicate over longer distances but may 
nevertheless be crucial to understanding the workings of the 
innovation. 
• Recognition of the role of experts and decision-
makers in innovation transfer and diffusion 
Growing evidence points to the key roles played by a wide 
range of experts and decision-makers in policy transfer and 
diffusion. These include individuals who serve as ‘policy 
entrepreneurs’ or ‘policy ambassadors’, promoting or 
pushing service or policy innovations; organizations 
(universities, think tanks, international organizations) and 
networks, including knowledge networks that are based on 
a shared scientific interest, and research and policy 
networks, which bring together actors from civil society, 
government, the professions and industry. An increasingly 
important role in the exchange and/or promotion of policies 
can also be seen for national and international meetings and 
conferences, and in the context of Europe, the EU 
institutions. 
But there remain several aspects of innovation 
transfer that we need to understand better 
The review of the conceptual literature has identified a 
number of gaps in our understanding about the transfer and 
possible scaling of promising service and policy innovations. 
These are: 
• The system context within which innovations are 
being introduced  
There is currently little evidence around the particular 
characteristics of health systems that are conducive to 
adopting, implementing and sustaining service and policy 
innovations. We also lack sufficient knowledge of the wider 
health system context and its elements, and how this relates 
to transferability of innovations. 
• The arrangements at the different levels of the 
system and their impact on the transfer of service 
and policy innovations across regions and countries  
Several countries have established formal arrangements at 
the national level to support service innovation. However, 
there is as yet little evidence of the impact such initiatives 
have had, but also of how availability of such evidence could 
support successful transfer of innovations. Further, 
European-level actors can play an important role in both the 
development and spread of service and policy innovations, 
and we need to understand how innovations reach the 
European-level policy agenda and then spread across 
countries. Finally, the role of what has been referred to as 
‘transnational spaces’, such as summits, conferences, 
meetings and workshops, is also under-researched. 
 
• The nature of evidence needed to inform the transfer 
of service and policy innovations  
We know that policy-makers draw inspiration from a variety 
of sources, but they may prioritize certain kinds of 
information over others. We need to better understand the 
types of knowledge that policy-makers need in order to act 
upon international evidence as well as the degree to which 
existing knowledge facilitates the adoption and 
implementation of innovations. Also, the conditions under 
which specific knowledge types are used or the motivators 
that cause actors to select specific ‘knowledge claims’ are 
not very well understood. A related issue is the need to 
better understand transfer of ‘best practice’, which is often 
shared without context and presented in forms that are 
scant on both tacit and practical knowledge, which may be 
key for a successful transfer. Thus, there is an urgent need to 
systematically trace what gets lost in policy translation. 
Finally, there is a need for the further development of 
approaches that will help in understanding the transfer 
potential for relatively novel innovations, especially those 
that are at an early stage in just a small number of regions 
or  countries, or are changing rapidly.  
• The impact of service and policy innovations on 
health system performance  
There is lack of robust research on how service and policy 
innovations impact the performance of the health system, in 
both the originating and the receiving system. A related 
challenge is that of unintended consequences of 
innovations, such as reinforcing or even increasing existing 
inequalities in a given population. There is thus the need for 
much better understanding of how to best design (and 
transfer) innovations to avoid this. 
• Research methodologies to advance cross-country 
research  
While we often look for inspiration in countries that are 
historically or geographically close, or share other similarities, 
we may miss valuable opportunities for mutual learning 
from other settings. There is thus a need to develop more 
systematic and rigorous approaches to identifying country 
‘units’ for comparison in order to optimize learning. New 
methodological approaches may also be needed to improve 
the study of the context required for the successful transfer 
of innovations. Finally, there is an urgent need to improve 
the empirical evidence base to inform transfer, including 
through better data, improved measurement approaches 
and longitudinal studies that look into the impacts of 
innovations. 
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1. Introduction: What is the problem?  
Health systems globally face numerous challenges. While 
there have been significant advances in people’s health and 
life expectancy in Europe (WHO Regional Office for Europe, 
2018), relative improvements have been unequal between 
and within countries (Barber et al., 2017). Key pressures arise 
from the rising burden of chronic health problems and of 
multimorbidity, which, along with population ageing and 
increasing frailty at old age, lead to growing demand on 
already stretched services. Advances in medical and digital 
technologies have considerable potential for novel ways of 
organizing and delivering care. But countries have to ensure 
that any such technology is used effectively and 
appropriately, and at a cost that is affordable, with 
associated changes carefully balancing growing consumer 
expectations and respecting people’s needs, wants and 
preferences (Elshaug et al., 2017). At the same time, many 
countries are facing shortages and an uneven distribution of 
health and care professionals, and there is a need to develop 
policies for the effective recruitment and retention of health 
and allied care workers within a changing context of service 
delivery, which requires adjustments to the composition and 
skills of those providing care (Barriball et al., 2015). These 
challenges come against a background of persistent and, in 
some settings, rising health inequalities and inequities in 
access to and utilization of health care services (Elstad, 
2016).  
Policy-makers in European health systems have recognized 
these challenges (WHO European Ministerial Conference on 
Health Systems, 2008; European Commission, 2014), but 
they have often had considerable difficulty translating this 
recognition into large-scale, sustainable and effective 
strategies for system and service organization and delivery. 
Approaches that would address the complexity arising from 
these various challenges sit at policy intersections between 
public health, health care and long-term care, and the wider 
regulatory framework within which these are embedded. 
Sustainable transformation must take account of these 
issues and consider the multifaceted set of interests and 
priorities of those involved in the organization, delivery and 
financing of services, which are likely to differ at the various 
tiers of the system and across different sectors.  
There is a clear need for innovative solutions to ensure that 
European health systems continue to provide accessible 
health and long-term care that is of high quality, responsive, 
affordable and financially sustainable, while also addressing 
the underlying determinants of health to improve population 
health overall. Countries in Europe have been embarking on 
a wide range of reform efforts, which reflect, largely, the 
different ways in which health systems are financed, 
organized and governed, and the wider context within 
which they operate (Nolte, Knai & Saltman, 2014). At the 
same time, there is great potential to learn from different 
countries’ experiences through comparative cross-national 
health services and systems research (Nolte et al., 2008). 
Cross-country comparisons help understand the range of 
approaches countries have adopted to address similar 
challenges and so allow the experience of each country to 
provide “an experimental laboratory for others” (OECD, 
2004). They offer opportunities for mutual learning and 
reconsideration of policies, cross-fertilization, or even policy 
transfer, where appropriate (see Box 1).  
 
Box 1: Uses of comparative cross-national health services and 
systems research 
Interest in learning from health policy, services and system experiences 
of other countries is not new and can be traced back to at least the 
19th century. A notable example includes the 1942 review conducted 
by Sir William Beveridge of existing national social insurance schemes 
(known as the Beveridge Report) to inform welfare policies in Britain 
(Sigerist, 1943). It was however only from the 1960s that systematic 
cross-national comparisons became an increasingly important field in 
social science research to support learning (Weinerman, 1971; 
Mechanic, 1975).  
There are different ways of thinking about comparative research in 
health services and systems (Marmor, Freeman & Okma, 2005):  
• Learning about national health systems and polices: cross-national 
investigation can help better understand a country’s own situation 
through comparison to clarify the policy problems to be addressed 
and the options that may be available (Marmor, 2017). Such 
knowledge does not necessarily offer actual lessons that can be 
learned from elsewhere, but an international perspective can inform 
policy development.   
• Learning why health systems and policies take the forms they do. 
This type of analysis aims to explain why systems and policies exist 
the way they do and why they have developed in a certain way. They 
often seek to explain an observation from which to generalize by 
identifying factors that appear relevant to generating a particular 
outcome (Cacace et al., 2013). 
• Learning from other countries for potential application of policies 
elsewhere. This type of study aims to understand processes and 
developments in one group of countries to inform policy learning in 
another. It sees cross-national experience as ‘quasi-experimental’ to 
draw lessons for possible transfer. It typically focuses on particular 
policy challenges common across countries and seeks to identify 
‘best practice’ and/or potential for policy translation or, possibly, 
transfer. 
Each approach can provide important insights and is equally relevant 
as it will help inform learning from elsewhere (Cacace et al., 2013). 
 
 
Importantly however, in order for such learning to be 
effective, there is a crucial need to identify and understand 
what contributes to successful innovation in health services 
and policies, what needs to be in place for such innovations 
to be implemented more widely, and what we can learn for 
their possible translation to other settings within and across 
countries. 
This policy brief seeks to contribute to this debate by first 
describing what we mean by innovative solutions in health 
services and policies and, specifically, why we need research 
on ‘service and policy innovation’ in health systems. We then 
present a synthesis of the evidence of what we know, and 
what we do not know, about the conditions for and 
determinants of successes and failures in the transfer (and 




regions and countries. We particularly focus on gaps in our 
current knowledge and understanding of the transferability of 
service and policy innovations in health. Such understanding 
will help in shaping the European Partnership on Health and 
Care Systems Transformation to support closing these 
important gaps and so contribute to generating the much-
needed evidence to inform the further development of 
resilient, effective, equitable, accessible, sustainable and 
comprehensive health services and systems in Europe and 
elsewhere. 
 
2. What we mean by ‘innovative solutions’ in 
health systems in the context of this brief  
What is ‘innovation’? 
 
“In the 17th century, ‘innovators’ didn't get accolades.  
They got their ears cut off.” (Green, 2013) 
 
The origins of the idea of ‘innovation’ can be traced back to 
ancient Greece, where it was used to describe changes to 
laws and political constitutions (Godin, 2008). Before the 
20th century, innovation tended to be considered critically, 
or was even opposed. It was only from the mid-20th century 
or so that innovation came to be viewed as a positive 
‘thing’, now widely perceived as “the emblem of the 
modern society, a panacea for resolving many problems” 
(Godin, 2008).  
Innovation is most often linked to technologies, but there 
are other forms. A basic distinction is that between 
technological and non-technological innovation (OECD, 
2005). Technological innovation includes product innovation 
(goods or services that are new or significantly improved) 
and process innovation (a new or significantly improved 
production or delivery method). Non-technological 
innovations include organizational innovation, that is, a new 
organizational method in business practices, workplace 
organization or external relations (OECD, 2005). Others have 
delineated political, educational and social innovation 
(Godin, 2014).  
In many ways, innovation can be seen as an overarching 
idea that is widely and variedly used and interpreted, 
reflecting different sectors, disciplines and perspectives. In 
Box 2 we set out the common attributes of innovation 
identified in the literature. 
 
 
Box 2: Common attributes of innovation 
At the core of any (definition of) innovation is the idea of novelty. For 
example, Rogers (1983) defined an innovation as “an idea, practice, 
or object that is perceived as new by an individual or other unit of 
adoption”. The idea of novelty is of course also key to any form of 
invention. The main difference between an invention and an innovation 
is application; an innovation is something that can be used in practice 
(Witell et al., 2016). Inventions include any new product, service, 
process or idea but they must be introduced or adopted and used in a 
way that provides utility to society and that can be diffused to be 
considered an innovation (Sener, Hacioglu & Akdemir, 2017). In 
addition to the idea of novelty, an innovation also presents a 
discontinuous change (which can be small), that is, a break in business-
as-usual. Viewed this way, innovation is different from organizational 
learning, which typically involves smooth, continuous development 
whereas innovation creates “jumps in evolution” (Toivonen & 
Tuominen, 2009). Innovation thus presents different managerial 
challenges compared to say, incremental organizational change or 
service development (Osborne & Brown, 2011). Finally, innovation can 
be understood as both a process (the process of innovating) and an 
outcome (innovation/s produced in the process) (Osborne, 1998). 
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Focusing specifically on health service delivery and organization, 
Greenhalgh et al. identified key features of innovation as:  
• a novel set of behaviours, routines and ways of working  
• directed at improvement of health outcomes, efficiency, cost-
effectiveness or users’ experience  
• implemented by planned and coordinated actions (Greenhalgh et al., 
2004b).  The types of innovation that fall within this definition are 
wide ranging. It considers new technologies, such as digital 
technologies (e.g. eHealth); new procedures (e.g. minimally invasive 
surgery); the creation of new roles (e.g. nurse practitioners in primary 
care); the relocation of services from hospital into the community; 
the creation of new services (e.g. case management); or the 
introduction of new models of care (e.g. integrated delivery systems). 
All of these will have significant impacts on ways of working (Nolte, 
2018). 
Source: Adapted from Nolte, 2018. 
 
 
Why we need research on ‘service and policy  
innovation’ in health systems 
In the health sector, a wide range of activities are often 
collectively referred to as innovations, such as new ideas, 
beliefs, knowledge, practices, programmes and technologies 
(Dearing, 2008).  
Technological innovation remains core and there are many 
examples of how the development of new technologies, 
such as drugs, diagnostic tools and therapies, have been key 
to improving population health globally. Prominent 
examples range from the discovery of penicillin and insulin in 
the early 20th century, along with the development of 
vaccines, safe anaesthesia and, more recently, antiretroviral 
therapy for HIV, to advances in diagnostic testing and 
imaging. However, to benefit populations, these discoveries 
all required addressing a series of policy questions such as:  
• Who delivers the technology?  
• Who will pay for it and how? 
• Who ensures that people will be able to access the 
technology and how? 
• What is the most appropriate setting for delivering the 
technology? 
• Who ensures that there are sufficient supplies of the 
technology and the people delivering it? 
• Who monitors that the new technology achieves the 
intended effects and how?  
Thus, introducing new technologies into a given system will 
have important consequences for how health services are 
being organized, funded and delivered. For this to be 
successful, a good understanding of the organizational 
context within which they are being implemented will be 
essential (Greenhalgh et al., 2004a). Lack of attention to the 
wider context within which services and systems operate can 
have considerable implications for the successful 
implementation and spread of such innovations (Nolte, 
2018). A useful illustration of this situation is that of the 
introduction of digital technologies in the health sector. 
While seen as a means to strengthen person-centred health 
services and systems by bringing services closer to people 
and engaging them in their own care, the track record of 
the implementation, sustaining and spread or scale-up of 
digital technologies has remained poor (Greenhalgh et al., 
2017). This is, in great part, because the introduction of new 
technologies often occurs without taking account of the 
wider organizational and systems changes that are required 
to embed these technologies into daily practice (Standing et 
al., 2016) (see also Box 3). Some commentators have noted 
that large-scale  policy initiatives to rapidly implement 
telehealth technologies “despite known uncertainties 
around complexity, costs and benefits … have led to what 
might be considered inappropriate allocation of finite 
resources” (Wilson, Boaden & Harvey, 2016). Indeed, in 
France, the implementation of the personal electronic 
medical record was considered to have not succeeded 
because of failure to adapt the health system accordingly; 
this was estimated to have caused a loss of €210 million 
between 2004 and 2011 (Cour des comptes, 2012). 
 
 
Box 3: Why the implementation of eHealth systems may fail: 
the importance of context 
A 2012 review of reviews of the implementation of eHealth systems 
found that policies or implementation strategies generally did not 
consider the wider social context within which eHealth systems were 
to be introduced (Mair et al., 2012). Questions about the purpose and 
benefits of such systems and their anticipated value to users were 
neglected, as were the likely impacts that eHealth technologies would 
have for the roles and responsibilities of different end users (staff, 
patients), and the need to adapt systems to the local context. 
Lack of attention to the wider context within which digital health 
technologies are being introduced was found to be a major 
impediment to the implementation of a national digital health 
innovation programme in the United Kingdom (Lennon et al., 2017). 
The programme involved a wide range of products and services (mobile 
applications (apps), personal health records, telecare, telehealth, 
wearable activity trackers, etc.) to enable preventive care, self-care and 
independent living at scale. There was a range of barriers to the 
embedding of technologies into daily practice at all tiers of the system, 
such as: lack of suitable information technology infrastructure; 
uncertainty around information governance; lack of incentives to 
prioritize interoperability; lack of precedence on accountability within 
the commercial sector; and a market perceived as difficult to navigate. 
Source: Adapted from Nolte, 2018. 
 
 
But, and perhaps more importantly, the effectiveness and 
impact of new technologies in health systems will be 
affected by the way health services and systems are 
organized. Indeed, the introduction of such technologies 
requires innovation at organizational, service and system 
level, too, to ensure that they will benefit populations and 
society as a whole. At the same time, and given the complex 
challenges health services and systems are facing, it will be 
essential to focus on innovation in service organization and 
delivery and policies. Such innovations need to stretch the 
entire continuum from health promotion and disease 
prevention to long-term and end-of-life care.  
There are many examples of evidence-based service and 
policy innovations. Thus, there is now considerable evidence 
suggesting that many health promotion and disease 
prevention interventions are highly cost-effective (McDaid, 
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2018). For example, an increasing number of countries have 
put in place salt reduction strategies. But there remains 
uncertainty about the factors that are most important to the 
successful implementation of related programmes (Trieu et 
al., 2015), and overall investment in relevant policies has 
remained low in many countries in Europe. 
Examples of innovation in service delivery include the 
introduction of organized care for people who have had a 
stroke (Stroke Unit Trialists' Collaboration, 2013) and the 
centralization of stroke services, which have been shown to 
significantly improve clinical outcomes among stroke 
patients (Morris et al., 2019). But similar to the example of 
salt reduction policies, despite the strong evidence base, 
approaches to stroke management and care continue to vary 
widely across Europe (Aguiar de Sousa et al., 2019). This 
highlights the need to better understand the factors acting 
at service and system levels that enable (or indeed hinder) 
the successful implementation of evidence-based stroke 
care across the region.  
There is thus considerable potential to learn from the many 
experiences of countries across Europe by means of 
systematic, comparative cross-country health services and 
systems research. But as the examples above illustrate, we 
need to better understand the factors that contribute to the 
successful implementation of innovative health services and 
policies in different settings, plus the prerequisites of, as well 
as conditions for, their wider dissemination and 
implementation within and across countries to ensure 
learning that is effective. This might also mean deciding not 
to transfer a given service or policy innovation where 
relevant conditions are not suited or cannot be met for 
political, economic, social or other reasons. 
 
3. What we know about the transfer  
of service and policy innovation 
There are many examples of cross-national learning and 
transfer of innovation in public (health) policy. The spread of 
social (health) insurance systems across many countries in 
western Europe from the late 19th century (Mountin & 
Perrott, 1947; Saltman & Dubois, 2004) provides one such 
example, illustrating how domestic policies are shaped by 
international influences and relations between nation states 
(Obinger, Schmitt & Starke, 2013). In an increasingly 
globalized world, cross-national learning is inevitable, as 
countries and societies do not act independently of each 
other because of multiple interdependencies, which will 
impact on the policy choices of countries.  
Understanding when, why and how policy (and, by 
extension, service) innovations move between countries has 
been the subject of much political and social science 
research, most prominently within the policy diffusion and 
policy transfer literature. It is beyond the scope of this brief 
to synthesize this vast and diverse literature. Box 4 presents 
a brief summary overview of the main concepts.  
 
 
Box 4: Understanding policy movements: concepts and  
literatures 
A range of concepts are concerned with ‘policy movement’ between 
countries (Stone, 2017). These include policy diffusion, policy learning, 
policy transfer and policy mobility, with the most recent idea of ‘policy 
circulation’ introduced as an overarching term to capture “the work 
involved in moving policy and the ongoing nature of such efforts” 
(Baker & Walker, 2019).  
Policy diffusion studies date back to the 1960s, seeking “to map and 
explain sequential patterning related to the uptake of ‘policy 
innovations’ … and to understand when and why certain jurisdictions 
adopt policies from other jurisdictions” (Baker & Walker, 2019). 
Relevant studies often refer to the idea that policy choices converge as 
regions or countries adopt the policies of ‘innovator’ regions or 
countries. Policy diffusion research most often relies on quantitative 
methodologies (Obinger, Schmitt & Starke, 2013).  
Policy learning studies emerged partly in response to diffusion studies 
that focused on the sequence of diffusion but provided less insight into 
the processes by which policy transfer occurs. Policy learning emerged 
in the 1990s, with the work of Richard Rose particularly influential in 
his attempts to understand the process of policy movements – or what 
he called ‘lesson drawing’, which is understanding the ways that policy-
makers source, assimilate and apply knowledge (Rose, 1991). This 
concept recognizes that policy-makers operate within a given context, 
which influences (constrains) “truly rational decision-making”. 
Policy transfer studies date back to the late 1990s in the context of 
growing economic globalization and the rise of international 
organizations. Building on Rose’s notion of lesson-drawing, policy 
transfer is “the process by which knowledge about policies, 
administrative arrangements, institutions and ideas in one political 
system (past or present) is used in the development of policies, 
administrative arrangements, institutions and ideas in another political 
system” (Dolowitz & Marsh, 2000). Policy transfer stretches the 
continuum from lesson-drawing as a voluntary process to coercive 
transfer. More recent work has (re-)interpreted policy transfer as 
shifting away from the idea of ‘transfer’ as such towards an 
understanding that policies are transformed ‘by their journeys’ from 
one setting to another one. Policy mobility studies are characterized 
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by their focus on understanding how policies “change or mutate as 
they move” (Lovell, 2019). They acknowledge that policy is increasingly 
being made “beyond formal, official government channels and venues 
by a range of non-state actors or intermediaries, such as multi-national 
companies and consultants” (Lovell, 2019) and that policy-makers 
‘learn’ through a much larger range of activities. It highlights the 
importance of ‘space’ in that policy-making is not confined to a state 
territory or a particular place and then moves but involves “fixed or 
mobile pieces of expertise, regulation, institutional capacities, etc. that 
are brought together in particular ways and for particular interests and 
purposes” (McCann & Ward, 2012). 
Source: Adapted from Baker & Walker, 2019. 
 
 
The comparative policy literature has highlighted the role of 
differences in the organization, financing and governance of 
health systems, and their role in health system performance. 
Yet, what is less well known is how service and policy 
innovations may explain differences in performance. 
Likewise, the literature on evaluation and implementation 
research has examined the factors influencing the 
implementation of service and policy innovations and for 
achieving the intended effects. But what we do not yet fully 
understand are the specific conditions under which a given 
service or policy innovation that has been successful in one 
setting can be transferred to another one.  
Here we summarize the evidence of what we know, and 
what we do not know, about the conditions for and 
determinants of successes and failures for the transfer (and 
possible scale-up) of service and policy innovations between 
regions and countries. The evidence review was guided by a 
conceptual framework, which may also serve as a basis for 
guiding strategic comparative research and assessment 
 (Figure 2). 
The framework highlights the key elements that we have 
 investigated further in our review, focusing on: 
• features of the service or policy innovation  
• characteristics of the originating and receiving systems  
• the process of translation and transfer. 
Figure 2: Conceptual framework: conditions for and determinants of successes and failures for the transfer of service and policy 
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Key to the transfer of any innovation is a good 
 understanding of its main features  
There remains a debate about the level of detail and nature 
of what precisely it is we need to know or whether emphasis 
should be on the mechanisms that make the innovation 
‘work’ (Box 5). 
 
 
Box 5: Attributes of innovation that facilitate its adoption and 
implementation 
Greenhalgh et al. (2004a), based on a systematic review of the 
theoretical and empirical evidence on the diffusion of innovations in 
service organizations, noted that innovations are more easily adopted 
and implemented if: 
• the innovation has a clear-cut advantage in (cost-)effectiveness 
relative to alternatives  
• the innovation is compatible with the potential adopters’ values, 
norms and perceived needs; it ‘fits’ with established ways of 
accomplishing the same goal (Dearing, 2008) 
• the innovation is perceived by key stakeholders as ‘simple’ to 
understand and use (complexity) (also applies to more complex 
innovations that can be broken down into manageable components) 
• the innovation provides the opportunity for the intended users to 
experiment with it on a limited basis (trialability) 
• the benefits of the innovation can be seen by intended adopters 
(observability)  
• potential adopters can adapt, refine or otherwise modify the 
innovation to suit their own needs (reinvention). 
However, even where all these attributes are present, this does not 
guarantee adoption of a given innovation. This is because decisions 
about adopting do not occur in isolation; indeed, it is “the interaction 
among the innovation, the intended adopter(s), and a particular 
context that determines the adoption rate” (Greenhalgh et al., 2004a). 
 
 
Service or policy innovations differ in their level of 
complexity. It has been argued that more complex 
innovations are more difficult to transfer (Rose, 1991), 
although there are examples of relatively complex 
innovations that have been implemented in many health 
systems, such as diagnosis-related groups (DRGs) as a means 
to pay for hospital services (Box 6).  
However, there are different components of ‘complexity’: 
those relating to the innovation itself; the number and 
diversity of stakeholders involved in implementation and 
transfer; the interactions between different actors with the 
innovation and with the context from which it originates 
and is being transferred into – among other aspects. 
Relatively technical innovations (such as DRGs, see Box 6) 
might be easier to transfer than more ‘politicized’ reforms 
(Obinger, Schmitt & Starke, 2013). But even more technical 
innovations may be difficult to transfer where the wider 
institutional, political or societal context of the receiving 
system is not ready or receptive, such as in situations of 
‘involuntary’ transfer. 
 
Box 6: Global diffusion of DRGs: characteristics  
of the innovation 
DRGs were first introduced in the USA in 1983 as part of a prospective 
payment system for hospitals under Medicare to control hospital 
spending (Chulis, 1991). Described as “the single most influential post-
war innovation in medical financing”, because it shifted the balance 
of power between the health care providers and payers (Mayes, 2007), 
DRG-type systems have been introduced in a number of high-income 
countries, although the degree to which they are used for payment 
purposes varies (Geissler et al., 2011). 
Kimberly, de Pouvourville & D'Aunno (2008) carried out a systematic 
assessment of the factors that are likely to have influenced the global 
diffusion of DRGs (or more specifically, patient classification systems), 
which reflect, in part, those described in the wider diffusion of 
innovation literature (Greenhalgh et al., 2004b), while also highlighting 
key features of DRG-type systems (Kimberly, de Pouvourville & 
D’Aunno, 2008). Key among these are the characteristics of the 
innovation: 
• DRGs are flexible and relatively easy to modify, which contributes to 
their acceptance by potential users 
• DRGs are both a set of principles and a technology, and thus can 
serve the interests of a range of potential users 
• DRG systems are adaptable to local context, and they are continually 




The implementation literature has highlighted the 
importance of evidence of effect for the sustainability and 
spread of innovations within and across countries 
(Greenhalgh et al., 2004a). However, what remains less well 
understood is the nature of evidence that is required, 
ranging from controlled trial evidence to local information 
and evaluation studies. And while evidence of effectiveness 
of a given innovation is an important condition, this is in 
itself does not guarantee its adoption elsewhere.  
The sociocultural context is crucial for understand-
ing the potential for transferring service and policy 
innovations  
There is commitment, at European level, to the overarching 
values of universality, access to good quality care, equity and 
solidarity (Council of the European Union, 2006), but the 
extent to which health systems realize these values varies 
between countries as do the wider societal values among 
populations across Europe (Hofstede, 1983). Understanding 
the value systems underpinning service structures and 
policies will be important in the assessment of the 
transferability of a given innovation.  
Policy-makers and researchers tend to look to certain 
countries for examples of innovation. The choice is typically 
informed by geography (neighbouring countries), past 
(shared) history, language or the availability of published 
evidence (Stone, 2017). Overall, there is little robust 
evidence around the particular characteristics of health 
systems (both the originating and the receiving systems) that 
are conducive to the transfer of service or policy innovations 
to other systems, although there are tools to help analyse 
system characteristics systematically (WHO, 2000).  
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Key to any transfer is understanding whether and how the 
service or policy innovation in a given setting will address the 
policy challenge in the receiving setting. The underlying 
policy problems might differ between the originating and 
the receiving systems, as might the urgency of the problem. 
Depending on the degree to which the policy problems are 
(dis)similar, this may mean that the innovation in question 
will need to be adapted to meet the receiving country’s 
policy needs, or it may turn out not to be suitable to address 
the policy problem, meaning other options need to be 
explored. The diffusion of DRGs across European countries 
illustrates some of these issues, as shown in Box 7.  
 
 
Box 7: Global diffusion of DRGs: characteristics  
of the receiving health system 
In their assessment of the factors that are likely to have influenced the 
global diffusion of DRGs, Kimberly, de Pouvourville & D'Aunno (2008) 
described a number of key features of the health systems that 
‘imported’ DRGs from the USA: 
• DRG-type systems are essentially concerned with accounting for 
resource allocation and use in the health sector and, as such, of 
relevance to countries where health system performance is viewed 
as a priority: 
– Portugal introduced DRGs in 1984 as a basis for hospital budget 
allocation, with all public hospitals included from the early 1990s. 
DRG-based resource allocation was introduced in the context of 
chronic underfinancing of public hospitals at that time and there 
was an expectation that it would encourage the efficient 
utilization of resources to improve productivity and reduce 
uncontrolled cost expansion in the public health care sector 
(Mateus, 2011). 
• The prospect of the ability to control costs (as was the case for its 
original introduction in the USA) was potentially of relevance to all 
systems concerned with controlling costs in the health sector, but 
the urgency of addressing the ‘problem’ differed: 
– Countries with relative economic stability may have had less 
pressure to adopt a system such as DRGs. Thus, Denmark and 
Sweden experimented early with DRGs but lagged in their 
implementation, possibly because they did not face the same 
pressures as, for example, the USA. 
• Countries with more fragmented political and health systems may 
have more difficulty adopting DRG-type systems because of the wide 
range of actors involved: 
– Examples include Italy, Switzerland, Denmark, Germany and 
Sweden, where the (decentralized and fragmented) structure of 
government decision-making is seen to have slowed the adoption 
of DRGs (there will be “too many people to convince” to promote 
diffusion) (Kimberly, de Pouvourville & D'Aunno, 2008). 
Conversely, more unitary and centralized systems (e.g. Portugal) 
demonstrated that once the decision was made to adopt DRGs, 




The urgency of a problem might influence the willingness to 
look for innovations developed elsewhere. However, the 
perception of the level of urgency and problem definition itself 
are likely to differ among stakeholders at the various tiers of 
the system, from policy level to organizational level and the 
individual service user level.  
We have repeatedly highlighted the importance of ‘context’, 
but definitions of context vary, as does the interpretation of 
what precisely it is about context that is relevant to the 
successful transfer of innovations (Box 8). Wang, Moss & Hiller 
(2006) describe context as “the particular social and cultural 
environment and the particular political and organizational 
system in a society”. More recent understandings have moved 
away from the idea of context as a static concept and 
emphasized the dynamic nature of implementing and 
transferring innovations, noting that context comprises not 
only “a physical location but also roles, interactions and 
relationships at multiple levels” (Pfadenhauer et al., 2017). 
This also means that the process of transfer will be influenced 
by and shape the innovation, and these relationships are likely 
to change over time (Nolte, 2018). This will all impact on the 
transferability of innovative practices.  
 
 
Box 8: The importance of context for transfer: the Evercare 
model for case management  
The Evercare model was developed in the late 1980s for the Minnesota 
government by UnitedHealth Group, a for-profit health plan in the 
USA. A form a case management, this model of care seeks to address 
the needs of high-risk patients in particular, through the provision of 
preventive and responsive care for patients at high risk of deterioration 
in their health. 
The Evercare approach to case management has been associated with 
reduced costs of care for older people living in nursing care homes in 
the USA. This was achieved through the reduced use of health services 
such as hospitalizations and emergency services. The approach was 
subsequently adopted in England, with policy-makers envisaging 
Evercare's experience as a means to free up hospital resources through 
targeted case management of high-intensity users or people at high 
risk of hospitalization.  
Starting with pilots of the Evercare model of case management of frail 
elderly people in nine areas (primary care trusts) in England from April 
2003, case management subsequently became part of the 
government's national policy for supporting people with chronic 
conditions. The 2004 NHS Improvement Plan stipulated the 
introduction of case management in all primary care trusts through the 
appointment of senior nurses (community matrons) by 2007. The 
anticipated benefits included improved quality of care and, by 
preventing or delaying complications, reduced (emergency) admissions 
and long hospital stays. 
Yet these expectations did not appear to be justified. Evaluation of the 
Evercare pilot in the NHS in England failed to find the gains in lower 
emergency admissions and bed-days that would have been expected 
based on the potential cost savings suggested for the Evercare model 
in the USA. There are several reasons why the evaluations were unable 
to replicate the findings seen in the USA. In addition to likely 
differences in evaluation design, it was noted that the intervention 
identified previously unmet need, which may have affected the lack of 
association found in England (Gravelle et al., 2007). A 2015 meta-
analysis of the effectiveness of case management in primary care 
highlighted the importance of contextual factors, with, for example, 
countries with a low-strength primary care system, such as the USA, 
more likely to show beneficial effects (Stokes, 2015). 
Source: Nolte & McKee, 2008. 
 
 
Innovations have to be translated and customized 
to improve ‘fit’ with local conditions 
There is increasing recognition that innovations (however 
defined) will need to be adapted to the receiving context 
(‘the mechanism’ by which they work); that is, they have to 
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be translated and customized ‘to improve “fit” with local 
conditions’ (Stone, Porto de Oliveira & Pal, 2019). This 
requires understanding of a range of processes involved 
along the transfer pathway. These include:  
• the immediate context within which an innovation 
‘works’ (e.g. organization, region) in the originating 
setting will have been influenced by the innovation itself 
and its workings are also affected by the wider system 
context within which it sits; these factors might combine 
to impact behaviour and the outcomes produced (Dalkin 
et al., 2015) 
• translation or adaptation already occurs as services or 
policies move because different actors will bring different 
interpretations to the process well before the innovation 
has been transferred; here, networks, conferences, 
meetings and other fora often have an important role as 
a “locus for policy transfer” (Stone, Porto de Oliveira & 
Pal, 2019) 
• the nature of knowledge about the innovation includes 
codified, documented information that is more readily 
available, as well as tacit, local ‘know-how’ or insider 
knowledge; tacit knowledge is more difficult to 
communicate over longer distances, but may be crucial to 
understanding the workings of the innovation (Lovell, 
2019). 
 
Growing evidence points to the key roles played by a wide 
range of (densely networked) experts and decision-makers 
both within and outside government and (inter)national 
organizations in policy transfer and diffusion (Stone, Porto 
de Oliveira & Pal, 2019). These include: individuals (‘policy 
entrepreneurs’ (Dolowitz & Marsh, 2000) or ‘policy 
ambassadors’ (Porto de Oliveira, 2020) who promote or 
push service or policy innovations at local, regional, national 
or international levels, typically operating within or through 
knowledge networks); organizations (universities, think 
tanks, international organizations such as the EU, World 
Bank, UN agencies); and networks. Stone, Porto de Oliveira 
& Pal distinguish knowledge networks (which are based on a 
shared scientific interest and research) and policy networks 
(which bring together actors from civil society, government, 
the professions and industry, and are viewed as a “vehicle 
for knowledge diffusion and policy transfer”) (Stone, Porto 
de Oliveira & Pal, 2019). An increasingly important role can 
also be seen for national and international meetings and 
conferences as venues for the exchange and/or promotion 
of policies (Porto de Oliveira & Pal, 2018). Again, the 
example of the global diffusion of a DRG-type system 
provides a useful illustration of the role of these different 
types of actors and networks, as discussed in Box 9. 
 
Box 9: Global diffusion of DRG: social actors 
Kimberly, de Pouvourville & D'Aunno (2008) identified a range of what 
they describe as ‘social actors’ who have been key in the diffusion of 
DRG-types systems globally. These include: 
• Carriers and champions: Among the key players driving the 
introduction of DRGs in the USA were researchers at the universities 
of Yale and Michigan, who acted both as carriers of DRG systems 
(i.e. individuals who ‘carry’ the concepts and principles of the 
innovation) as well as champions who support change and promote 
their use in practice (Mayes, 2007). As “outsiders, they had the 
advantage of being able to see the strengths of [DRGs]” but “they 
did not necessarily have the authority or power to be effective 
champions with the ability to implement changes such as [DRGs]” 
(Kimberly, de Pouvourville & D'Aunno, 2008). Kimberly and 
colleagues noted that the absence of such carriers/champions might 
explain why some countries have experimented with DRG-type 
systems but have not implemented them as fully as might have been 
possible. 
• Networks of users: The rapid spread of DRG-type systems to Europe 
and Australia was facilitated by a range of meetings and events, as 
well as the formation of expert networks around DRGs from the mid-
1980s (Wiley, 1992; Wiley, 2011). A defining feature of DRGs was 
the evolution of a DRG-focused ‘research industry’, which produced 
individuals with particular expertise in the analysis of DRGs 
(exemplified by the formation of the Patient Classification Systems 
International (PCSI) network) (Patient Classification Systems 
International, 2008). Such networks, Kimberly and colleagues argue, 
have not only facilitated information-sharing about DRGs as such 
but, more importantly perhaps, generated a sense of community and 
cohesion (as well as momentum), which provided “legitimacy and 
support that are needed to promote [DRGs] in the face of obstacles 
to their adoption and implementation” (Kimberly, de Pouvourville & 
D'Aunno, 2008). 
• Major stakeholders: Stakeholders have included, in addition to those 
who influence or make policy decisions, physicians, hospital 
managers and, where relevant (e.g. decentralized systems), regional 
health system managers. Kimberly and colleagues cite the example 
of Belgium, where strong opposition of physicians has meant that 
the implementation of a DRG-type system has lagged despite 
undertaking comparatively early research that was supported by the 
Ministry of Health in the late 1970s (Kimberly, de Pouvourville & 
D'Aunno, 2008). Where physicians were more involved in the 
development of the system from its inception, its acceptance by 
physicians was more likely (e.g. Hungary). Overall, and in line with 
the implementation and diffusion of innovation literature more 
widely, Kimberly and colleagues found that DRG-type systems were 
more likely to be adopted and implemented where key actors shared 
similar values and views on the benefits of such systems. 
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4. What we need to know about the  transfer of 
service and policy innovation 
Our review of the conceptual literature has identified a 
number of gaps in our understanding about the transfer and 
possible scaling of promising service and policy innovations, 
which we have identified as priority learning areas for 
European health services and systems research. These are: 
• understanding the system context within which 
innovations are being introduced  
• understanding the arrangements at the different levels of 
the system and their impact on the transfer of service and 
policy innovations across regions and countries 
• understanding the nature of evidence needed to inform 
the transfer of service and policy innovations  
• understanding the impact of service and policy 
innovations on health system performance 
• research methodologies to advance cross-country 
research. 
We describe each of these in turn. 
We need better understanding of the system 
 context within which innovations are introduced  
Understanding of the system context is of key importance 
for the adoption, implementation and sustaining of service 
and policy innovation and, in particular, for evaluating the 
potential and likelihood for these to be transferred 
elsewhere (Nolte, 2018). This includes understanding of 
both the context of the system from which the service or 
policy innovation originates and that of the receiving or 
adopting system.  
Clearly, health systems are complex, with differences at the 
various tiers of organization, governance and finance. But, 
as outlined above, there is little robust evidence on what 
characteristics of health systems are most conducive to the 
transfer of service or policy innovations to other systems. We 
also lack knowledge of ‘context’ and how this relates to 
transferability. Existing analyses of health system typologies 
might provide a useful starting point for characterizing what 
it is about context that we need to better understand 
(Marmor, Freeman & Okma, 2005). Box 10 provides an 
example of research that used an established welfare system 
typology to understand international variation in the 
effectiveness of pay-for-performance (P4P) schemes in 
primary care in a range of high-income countries, and which 
can help inform policy-makers elsewhere considering 
introducing such incentive schemes to understand the likely 
challenges they might face.  
 
 
Box 10: The influence of different welfare regimes on  
pay-for-performance in primary care 
There has been increasing interest globally in the use of P4P schemes 
in the health sector to improve the quality of services, encourage more 
efficient spending (Lagarde, Huicho & Papanicolas, 2019) and, 
ultimately, improve health outcomes. However, evidence of the impact 
of P4P programmes has remained mixed (Mendelson et al., 2017). 
There are many reasons for this inconsistency, such as variation in the 
design and complexity of relevant schemes, as well as in the system 
context in which they are being introduced. Ammi & Fortier (2017) 
studied how the social and institutional context of countries influenced 
the adoption of P4P programmes for general practitioners in 13 high-
income countries.  
Using Esping-Andersen’s typology of welfare regimes (liberal, 
corporatist, social democratic), they found that:  
• In liberal systems (Australia, Canada, New Zealand, United Kingdom, 
USA), funders were more willing to engage with, and professional 
and provider associations tended to be broadly supportive of, P4P; 
physicians tended to be “more willing to accept, participate and 
respond” to such programmes.   
• In corporatist systems (Austria, France, Germany, Italy), support for 
P4P programmes from professional and provider organizations was 
mixed; implementation tended to be delayed; physician participation 
was variable and generally lower than in liberal systems.  
• Social democratic systems (Denmark, Finland, Norway, Sweden) had 
shown a “distinct lack of interest in using P4P to reward general 
practitioners”, the only exception being Sweden. 
The study was limited in that it relied on publicly available, English-
language documents, introducing a bias towards English-language 
countries, along with variation in data availability for a range of P4P 
programmes studied. However, the study does provide an important 
illustration of a systematic approach to analysing the performance of 
a policy innovation (P4P programmes) and how this is impacted by 
different societal and institutional contexts, and vice versa. It also shows 
the potential of cross-national health services and systems research 
involving analysts from the studied countries to provide more detailed 
insight into the complex relationships between a policy innovation such 
as P4P with the range of actors and wider institutional framework, and 
how these influence adoption, implementation and roll-out – and, 
ultimately, the impacts of the innovation on individual, organizational 
and system-level outcomes. This can then help to inform other systems 
about the likely impacts of that innovation in their context.  
 
 
Successful cross-national learning not only requires analysis 
of the relevant institutions, but also of the wider political 
and economic system within which health systems operate, 
as these have clear implications for what is and what is not 
doable or acceptable in terms of service or policy innovation 
(Klein, 1997). An important part of context is also the role of 
‘social actors’, including international organizations and 
institutions, plus, in the context of Europe, that of the EU 
institutions in particular, which we explore in the next 
section.  
We need better understanding of the arrangements 
at different levels of the system and their impact on 
the transfer of service and policy innovations across 
regions and countries 
Several countries have established formal arrangements at 
the national level to support service innovation in particular. 
Examples include England (NHS England, 2018), Estonia 
(Ministry of Social Affairs, 2015) and Germany 
(Gemeinsamer Bundesausschuss, 2019), among other 
countries. However, we do as yet have little evidence of the 
impact such initiatives have had, and, importantly, how 
relevant evidence can also inform our understanding of the 
key health system requirements for the successful transfer of 
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innovations. Even if such evidence were available, it may not 
be easily accessible to international audiences if not 
published in the English language. Here, comparative 
analyses of national or regional strategies to advance service 
and policy innovations should be supported.  
Much of our discussion has focused on the transfer of 
service and policy innovation between health systems. Yet, 
there are also a number of European-level actors that play 
an important role in both the development as well as the 
spread of service and policy innovations. EU institutions have 
an important role to play through legislative measures, such 
as in relation to health and safety, and professional mobility. 
However, other actors, such as the device and 
pharmaceutical industries, professional bodies, patients’ 
organizations and the health service industry more broadly, 
are developing pan-European strategies to spread 
innovation.  
The role of what has been referred to as ‘transnational 
spaces’, such as summits, conferences, meetings and 
workshops that are being promoted by international 
organizations, networks or private actors, is under-
researched (Porto de Oliveira & Pal, 2018). There is a crucial 
need to better understand why some policies are circulating 
more than others, who the actors are that promote policies 
at the national, European or even global levels, and how 
policy translation is taking place. These ‘transnational 
arenas’ are not conflict-free and different actors will have 
various views on and interpretations of ‘facts’. It will be 
important to trace who drives the agenda and whose voices 
are being heard as well as whether certain groups are 
excluded from participating (Porto de Oliveira & Pal, 2018; 
Stone, Porto de Oliveira & Pal, 2019). 
There is thus a need for systematic and comparative social 
science, policy and economic studies of: the emergence of 
relevant service and policy innovations; how they reach the 
European-level policy agenda; and/or how they spread 
across European countries, in order to help understand the 
process of the transfer of innovations in health. Such 
analyses could also help to identify clusters of countries that 
share specific meso- and macro-level features (language, 
culture, health system features, actors) and their role in 
spreading or transferring innovations. 
We need better understanding of the nature of 
 evidence required to inform the transfer of service 
and policy innovations  
We need to better understand the types of knowledge that 
policy-makers and others need to possess in order to act 
upon international evidence, as well as the degree to which 
existing knowledge facilitates the adoption and 
implementation of service and policy innovations. We know 
that policy-makers draw inspiration from a wide range of 
sources, including everything from informal exchanges with 
policy-makers from other countries and site visits, to formal 
exchanges in the context of international meetings (Dobrow 
et al., 2006). However, policy actors “are not perfectly 
rational and […] they tend to privilege what they believe 
rather than accept information that might challenge those 
beliefs” (Moyson, Scholten & Weible, 2017).  
As noted earlier, we know about the range and nature of 
‘evidence’ or knowledge, from scientific evidence to ‘lay’ or 
‘common’ knowledge, all playing a role in policy learning. 
But the conditions under which specific knowledge types are 
used in policy learning and transfer, and the motivations for 
actors to select specific ‘knowledge claims’ are less well 
understood. This understanding is however crucial for 
assessing why a given service or policy innovation reaches 
the ‘promising to transfer’ agenda, or why it does not. 
Indeed, there is a lack of empirical evidence on why policies 
were not transferred; this may have been because successful 
polices were not recognized or because the policy 
innovation failed in the originating system (Lovell, 2019).  
A related issue is the widely used idea of ‘best practice’ in 
knowledge and policy networks (Porto de Oliveira & Pal, 
2018; Lovell, 2019; Stone, Porto de Oliveira & Pal, 2019). 
These are often promoted by international organizations or 
networks that bring together different administrations or 
groups, “each with its own interests”, but to make these 
acceptable to a range of potential ‘recipient’ countries or 
settings, these practices need to be translated and simplified 
(Porto de Oliveira & Pal, 2018). As a consequence, ‘best 
practices’ are often (although not always) shared without 
context, which can lead to incomplete or inappropriate 
transfer (see Box 11). Furthermore, best practices are often 
presented in codified form as reports, evaluations and other 
outputs, and thus run the risk of disregarding tacit and 
practical knowledge that has been generated locally (Lovell, 
2019), but which would be key to assessing the potential for 
a given service or policy innovation to be transferred and 
implemented elsewhere. Thus, there is an urgent need to 
systematically trace what gets or “is lost in policy 
translation” (Porto de Oliveira & Pal, 2018). 
 
 
Box 11: Why does policy transfer fail? 
The comparative policy literature has identified key instances for why 
policy transfer fails, including:  
• Uninformed transfer: policies are transferred without sufficient 
knowledge about why and how they work in the country or system 
of origin. 
• Incomplete transfer: some features of the policy are transferred but 
not others. But it may be the ‘other’ features that are important for 
the policy to work in the receiving country or system. 
• Inappropriate transfer: contextual factors (cultural, political, 
economic) are very different between the ‘donating’ and the 
‘receiving’ country or system, which will lead to differences in 
outcomes in the two systems (Dolowitz & Marsh, 2000). 
Stone added the successful transfer of unsuccessful polices, referring 
to instances of the implementation and transfer of services and policies 
that lack an appropriate evidence base and are instead informed by 
“myth rather than fact” (Stone, 2017). 
 
 
Challenges also arise from the relative novelty of some of 
the service and policy innovations that are not yet fully 
implemented in a given country but may be of interest 
elsewhere. These are typically not well documented and, 
without undertaking primary research, it is often only 
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possible to describe these innovations with limited scope for 
assessing their consequences. There is thus a need for the 
further development of approaches that help understand 
the transfer potential for service and policy innovations, in 
particular those that are at an early stage in only a small 
number of countries or which are changing rapidly.  
We need better understanding of the impact of 
 service and policy innovations on health system 
 performance 
There is a lack of robust research on how service and policy 
innovations impact the performance of the health system, 
both in the originating and the receiving system. As 
countries are seeking to address the different health system 
challenges we described earlier, there is a risk of duplicated 
or competing innovations. This has been identified as a 
significant, albeit frequently overlooked and even less 
studied, contextual factor (Pendharkar et al., 2016). 
Competing priorities may lead to disengagement, fatigue 
and uncertainty among stakeholders, and these may cause 
additional costs.  
A related challenge is that of unintended consequences of 
innovations, again an issue of concern for both the 
originating and the receiving system (Nolte, 2018). There 
may be a risk of innovations reinforcing or even increasing 
existing inequalities in a given population. Research in the 
USA has also shown that wealthy communities tend to 
adopt innovations early relative to poor communities 
(Dearing & Cox, 2018), and this experience highlights the 
need for a much better understanding of how best to design 
(and transfer) service and policy innovations to ensure they 
benefit all citizens. This is related to the capacity of 
organizations, regions or countries to absorb innovation. 
We need better research methdologies to advance 
cross-country research 
As noted earlier, when looking for inspiration and possible 
solutions to domestic problems or challenges, policy-makers, 
practitioners and researchers tend to look at countries on 
the basis of historical ties, geography, or similarity in the 
principal organization and financing of health care (for 
example tax-based vs statutory health insurance systems; 
centralized vs decentralized systems). Such an approach may 
be reasonable, as a common or shared history might reduce 
the number of ‘unknown’ or uncontrollable factors that are 
likely to impact the transfer of policies, such as acceptability 
of a given service or policy innovation. However, at the same 
time, it might risk missing valuable opportunities for mutual 
learning. There is an urgent need to develop systematic 
approaches to identifying country ‘units’ for comparison in 
order to optimize learning.  
We have highlighted the need for more systematic work to 
better understand the context for the transfer of innovations 
across systems. This may require innovative methodological 
approaches, too. One example is the ‘Collaborative Reflexive 
Deliberative Approach’ to systematically studying the 
implementation of team-based primary care systems in 
different countries that were more or less introduced at the 
same time (Russell et al., 2017). This approach enabled 
better understanding of the common contextual factors that 
were seen to have influenced the successful implementation 
of teamwork in primary care in different settings. The idea of 
parallel evaluation of innovations that address the same 
problem and come up in different health systems may help 
to enhance the comparability of studies and, by implication, 
the factors that have facilitated (or hindered) the successful 
introduction of service innovation.  
A continued challenge is the lack of longitudinal studies. 
Evaluations of innovations tend to be time-limited and are 
typically too short to systematically assess the long-term 
impacts of a given change (Nolte et al., 2012). As Moyson, 
Scholten & Weible (2017) have noted, “when quick, 
pragmatic policy changes are observed, they often do not 
result from policy learning”. A sufficient time frame for 
monitoring and evaluation will be of particular importance 
for studying the impacts of the transfer of innovations, 
especially for scaling up processes. A related challenge is 
that of readily available data and information about 
innovation activity in different countries that would help to 
inform policy development in a given setting.  
There are also several measurement problems in the study of 
transfer and implementation of service and policy 
innovations. Examples include measurement approaches to 
the readiness of health systems to learn from each other 
(Furnival, Boaden & Walshe, 2017) and relevant measures of 
capacity for innovation at different levels (organizations, 
health systems) (Harvey et al., 2010). There is a need to 
develop methods and tools to enable the systematic 
assessment of innovations from the perspective of 
transferability to other countries. Given the unpredictability 
of interactions between an innovation and an adopting 
organization or system, with many feedback loops, this may 
require the application of complex systems theory and the 




This policy brief has identified several gaps in our knowledge 
and understanding of the transferability of service and policy 
innovations in the health sector. These include: a lack of 
understanding of the context conducive to the transfer of 
innovation in both the country or system of origin and the 
receiving country; a need for better evidence on 
organizational arrangements at meso and macro levels and 
their impact on the transfer of service and policy 
innovations; a lack of understanding of the nature of 
evidence needed to inform the transfer of service and policy 
innovations; a need for better evidence on the factors that 
facilitate or hinder the implementation and scaling of 
innovations that originate from other countries or health 
systems; and for evidence on the impact of service and 
policy innovations on health system performance. A 
European partnership on transforming health and care 
systems can help to close these important gaps and so 
contribute to generating the much-needed evidence to the 
inform the further development of resilient, effective, 
equitable, accessible, sustainable and comprehensive health 
services and systems in Europe and elsewhere.
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